Literature DB >> 33872773

A GDF5 frameshift mutation segregating with Grebe type chondrodysplasia and Brachydactyly Type C+ in a 6 generations family: Clinical report and mini review.

Sanam Faryal1, Muhammad Farooq2, Uzma Abdullah3, Zafar Ali1, Saadia Maryam Saadi4, Farid Ullah4, Kamal Khan4, Yasra Sarwar4, Muhammad Sher4, Anuja Arora Chopra5, Shahid M Baig6.   

Abstract

Different mutations in the Growth/Differentiation Factor 5 gene (GDF5) have been associated with varying types of skeletal dysplasia, including Grebe type chondrodysplasia (GTC), Hunter-Thompson syndrome, Du Pan Syndrome and Brachydactyly type C (BDC). Heterozygous pathogenic mutations exert milder effects, whereas homozygous mutations are known to manifest more severe phenotypes. In this study, we report a GDF5 frameshift mutation (c.404delC) segregating over six generations in an extended consanguineous Pakistani family. The family confirmed that both GTC and BDC are part of the GDF5 mutational spectrum, with severe GTC associated with homozygosity, and with a wide phenotypic variability among heterozygous carriers, ranging from unaffected non-penetrant carriers, to classical BDC and to novel unclassified types of brachydactylies.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Brachydactyly; GDF5; Grebe chondrodysplasia; Pakistan

Year:  2021        PMID: 33872773     DOI: 10.1016/j.ejmg.2021.104226

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  2 in total

1.  A novel variant in the ROR2 gene underlying brachydactyly type B: a case report.

Authors:  Jiaqi Shao; Yue Liu; Shuyang Zhao; Weisheng Sun; Jie Zhan; Lihua Cao
Journal:  BMC Pediatr       Date:  2022-09-05       Impact factor: 2.567

2.  Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip.

Authors:  Stefan Harsanyi; Radoslav Zamborsky; Lubica Krajciova; Milan Kokavec; Lubos Danisovic
Journal:  Genes (Basel)       Date:  2021-06-28       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.